These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 1879991)
1. Chronotherapeutic study of furosemide in hypertensive subjects: a preliminary report. Fujimura A; Ohashi K; Ebihara A Int J Clin Pharmacol Res; 1991; 11(2):67-73. PubMed ID: 1879991 [TBL] [Abstract][Full Text] [Related]
2. Chronotherapy of trichlormethiazide in hypertensive patients. Fujimura A; Ohashi K; Ebihara A J Clin Pharmacol; 1991 Jan; 31(1):54-7. PubMed ID: 2045529 [TBL] [Abstract][Full Text] [Related]
3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic and pharmacokinetic study of a slow-release formulation of furosemide in man. Ebihara A; Tawara K; Oka T Arzneimittelforschung; 1983; 33(1):163-6. PubMed ID: 6681970 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Smolensky MH; Hermida RC; Portaluppi F Chronobiol Int; 2007; 24(1):171-81. PubMed ID: 17364587 [TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study. Lind L; Berne C; Pollare T; Lithell H J Hum Hypertens; 1995 Feb; 9(2):137-41. PubMed ID: 7752176 [TBL] [Abstract][Full Text] [Related]
7. Chronopharmacological study of furosemide in human subjects. Tateishi T; Fujimura A; Miura T; Ebihara A Int J Clin Pharmacol Res; 1988; 8(6):401-7. PubMed ID: 3253217 [TBL] [Abstract][Full Text] [Related]
8. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure. Cohen N; Golik A; Dishi V; Zaidenstein R; Weissgarten J; Averbukh Z; Modai D Miner Electrolyte Metab; 1996; 22(4):248-52. PubMed ID: 8807629 [TBL] [Abstract][Full Text] [Related]
9. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population. Kawabe H; Saito I; Saruta T Hypertens Res; 2005 Jun; 28(6):491-8. PubMed ID: 16231754 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h. Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and pharmacodynamics of furosemide in Middle Eastern and in Asian subjects. Abou-Auda HS Int J Clin Pharmacol Ther; 1998 May; 36(5):275-81. PubMed ID: 9629992 [TBL] [Abstract][Full Text] [Related]
13. Chronopharmacological study of furosemide; (VII). Influence of repeated administration on biochemical parameters in blood. Fujimura A; Ohashi K; Ebihara A Life Sci; 1990; 47(24):2277-81. PubMed ID: 2266791 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the antihypertensive effect of a retard preparation of furosemide (Lasix retard) in monotherapy of mild hypertension. Keoplung M J Med Assoc Thai; 1981 Dec; 64(12):624-9. PubMed ID: 6153030 [No Abstract] [Full Text] [Related]
15. Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure. Vitolo E; Segalini G; Carini L; Castini D; Moreo A; Mazzola C; Segagni S; Villa G; Salvadeo A Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):327-34. PubMed ID: 3209280 [TBL] [Abstract][Full Text] [Related]
16. [Changes in plasma volume and electrolytes after treatment of therapy-resistant hypertension with diazoxide and furosemide]. Kiesewetter R; Cebulla P; Herrmann RM; Stoll W Z Gesamte Inn Med; 1981 Sep; 36(17):627-30. PubMed ID: 7345809 [TBL] [Abstract][Full Text] [Related]
17. Long-acting and short-acting diuretics in the treatment of hypertension. Pupita F; Belogi M; Ansuini R; Campolucci G Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805 [TBL] [Abstract][Full Text] [Related]
18. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Bahijiri SM; Mira SA; Mufti AM; Ajabnoor MA Saudi Med J; 2000 Sep; 21(9):831-7. PubMed ID: 11376359 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808 [TBL] [Abstract][Full Text] [Related]
20. Treatment of benign essential hypertension with frusemide in different doses. Valmin K; Hansen T; Rønsted P Pharmatherapeutica; 1980; 2(5):296-304. PubMed ID: 7001489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]